Literature DB >> 15315513

The use of antiepileptic drugs--principles and practice.

Josemir W Sander1.   

Abstract

Up to 70% of people developing epilepsy may expect to become seizure free with optimum antiepileptic drug (AED) therapy. The remaining 30% are the most difficult to treat. Most patients are controlled on a single AED, but a small proportion requires a combination of two agents. Add-on therapy with a second drug, rather than substitution, may be a viable and rational approach in some patients, particularly if the first drug is relatively well tolerated. Precise classification of the type of seizures, as well as the epilepsy syndrome, together with careful recording of both seizures and adverse effects, are essential if rational management decisions are to be made. The goal of therapy should be complete seizure freedom with a single drug taken once or twice a day and without adverse effects. If control is difficult to achieve, the maximum tolerated dose of each drug should be explored, but a balance needs to be struck between adverse effects and control of seizures. In patients in whom treatment appears to be ineffective, the diagnosis of epilepsy and adherence to therapy should be reviewed. Drugs used in combination must be carefully selected, as poor adherence, drug interactions, and toxicity are more likely if more than one drug is prescribed. Agents are usually chosen according to seizure type, patient characteristics, and often by clinician preference. Those that are better tolerated have a low potential for pharmacokinetic and pharmacodynamic interactions, and those that can be easily introduced without any complicated titration schedule have an advantage.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15315513     DOI: 10.1111/j.0013-9580.2004.455005.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  55 in total

Review 1.  Review of therapeutic options for adjuvant treatment of focal seizures in epilepsy: focus on lacosamide.

Authors:  Juan Luis Becerra; Joaquín Ojeda; Enrique Corredera; Jesús Ruiz Giménez
Journal:  CNS Drugs       Date:  2011-12-05       Impact factor: 5.749

2.  Lacosamide for epileptic seizures in patients with co-morbidities and unusual presentations of epilepsy.

Authors:  Alba Sierra-Marcos; Pedro Emilio Bermejo; Raquel Manso Calderón; Angela María Gutiérrez-Álvarez; Catalina Jiménez Corral; Daniel Sagarra Mur
Journal:  CNS Drugs       Date:  2011-12-05       Impact factor: 5.749

3.  Topiramate versus carbamazepine monotherapy for epilepsy: an individual participant data review.

Authors:  Sarah J Nevitt; Maria Sudell; Catrin Tudur Smith; Anthony G Marson
Journal:  Cochrane Database Syst Rev       Date:  2019-06-24

Review 4.  Phenobarbitone versus phenytoin monotherapy for epilepsy: an individual participant data review.

Authors:  Sarah J Nevitt; Catrin Tudur Smith; Anthony G Marson
Journal:  Cochrane Database Syst Rev       Date:  2019-07-31

Review 5.  Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data.

Authors:  Sarah J Nevitt; Maria Sudell; Jennifer Weston; Catrin Tudur Smith; Anthony G Marson
Journal:  Cochrane Database Syst Rev       Date:  2017-06-29

Review 6.  Topiramate versus carbamazepine monotherapy for epilepsy: an individual participant data review.

Authors:  Sarah J Nolan; Maria Sudell; Catrin Tudur Smith; Anthony G Marson
Journal:  Cochrane Database Syst Rev       Date:  2016-12-06

7.  Seizures and epilepsy in children.

Authors:  Anita Sharma
Journal:  Indian J Pediatr       Date:  2013-09-19       Impact factor: 1.967

8.  Global campaign against epilepsy: assessment of a demonstration project in rural China.

Authors:  Wenzhi Wang; Jianzhong Wu; Xiuying Dai; Guangyu Ma; Bin Yang; Taiping Wang; Chenglin Yuan; Ding Ding; Zhen Hong; Patrick Kwan; Gail S Bell; Leonid L Prilipko; Hanneke M de Boer; Josemir W Sander
Journal:  Bull World Health Organ       Date:  2008-12       Impact factor: 9.408

9.  Recurrent seizures in patients with dementia: frequency, seizure types, and treatment outcome.

Authors:  Satish C Rao; Gerald Dove; Gregory D Cascino; Ronald C Petersen
Journal:  Epilepsy Behav       Date:  2008-10-08       Impact factor: 2.937

Review 10.  The long-term safety of antiepileptic drugs.

Authors:  Athanasios Gaitatzis; Josemir W Sander
Journal:  CNS Drugs       Date:  2013-06       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.